VELOR
For laboratory research use only · Not for human consumption
Shop
PERFORMANCE

Ipamorelin

5mg
$50.00
Ipamorelin 5mg product photograph
1
5 available · Ships within 48 hours
  • Third-Party Tested
  • Cold-Chain Handled
  • Concierge Support

Questions about this compound, specifications, or documentation?

Speak with the Concierge

Selective ghrelin-receptor agonist referenced in published literature investigating pulsatile growth hormone release and GH-axis receptor biology.

  • GH/IGF-1 axis research
  • Pulsatile GH-release literature
  • Cold-chain handled, third-party tested
VIEW BATCH COA
Independent lab verification · current batch
  • THIRD-PARTY TESTED
  • COLD-CHAIN HANDLED
  • TRACKED SHIPPING
  • QUALITY-FOCUSED SOURCING
SPECIFICATIONS
Product
Ipamorelin
Strength
5mg
Vial Size
5mg per vial
SKU
VLR-IPA-5
Batch / Lot
Current batch listed on COA
Storage
Refrigerate 2–8°C · protect from light
Form
Lyophilized powder
RESEARCH USE ONLY

Sold strictly for laboratory and research purposes — never for human consumption, food, drug, or cosmetic use. 21+ only. A standard we hold ourselves to, not just the law.

EDUCATIONAL OVERVIEW

About this compound

Context, not noise — what the research actually says.

WHAT IT IS

A GH-secretagogue research peptide studied in pulsatile growth-hormone signaling literature.

PERFORMANCE
KEY BENEFITS
  • Investigated in pulsatile GH-release research
  • Studied across IGF-1 downstream signaling
  • Referenced in growth-hormone axis literature
COMMON USES
  • Growth-hormone axis studies
  • Pulsatile GH-release research applications
  • Layered with adjacent pathway compounds
THINGS TO KNOW
  • Reconstitutes cleanly with BAC water
  • Refrigerate after reconstitution; protect from light
  • Research use only — not for human consumption
RELATED COLLECTION
Perform Research Collection

Pairs with Tesamorelin — Compounds referenced together in GH and IGF-1 signaling axis literature.

VIEW COLLECTION
COLLECTION PRICE
$90.00
STORAGE

Cold-chain handling

REFRIGERATED
Store unopened at 36–46°F (2–8°C).
RECONSTITUTED
Keep refrigerated. Do not freeze.
PROTECT FROM LIGHT
Original packaging until use.

Store unopened vials refrigerated at 36–46°F (2–8°C). After reconstitution, keep refrigerated and use within the timeframe specified by your laboratory practice. Protect from light. Do not freeze reconstituted solution.

SHIPPING

Shipping information

Insulated, tracked, and handled with care from our facility to yours.

PROCESSING
Ships within 48 hours of order confirmation.
COLD-CHAIN
Insulated packaging with ice packs for temperature-sensitive compounds.
TRACKED & INSURED
Tracking provided. Domestic delivery typically 2–5 business days.

Local pickup is available by appointment for customers in the Phoenix, Arizona area. See the full shipping policy for details, accepted payment methods, and scheduling.

FAQ

Common questions

SCIENTIFIC RESEARCH OVERVIEW · SRO

Scientific Research Overview

A structured summary of published scientific literature on this compound — provided for educational reference only.

Endocrine Research
RESEARCH SNAPSHOT
Research Category
Investigational selective growth-hormone secretagogue peptide
Biological Targets
  • Ghrelin receptor (GHSR-1a)
  • Growth hormone axis
Primary Areas of Research
Ghrelin-receptor signaling · Pulsatile growth-hormone release · Growth-hormone secretagogue pathway · IGF-1 axis physiology · Body composition research · Selective receptor pharmacology
Current Stage of Research
Preclinical and Human Clinical Research
WHAT IS IPAMORELIN?

Ipamorelin is a synthetic pentapeptide investigated in the scientific literature as a selective growth-hormone secretagogue receptor (GHSR-1a) agonist. It is structurally related to the growth-hormone-releasing peptide family and is studied for its ability to stimulate endogenous, pulsatile growth-hormone release without significant off-target effects on other pituitary hormones. Evidence spans preclinical models and early-phase human studies.

PRIMARY AREAS OF RESEARCH
  • Ghrelin-receptor signaling
  • Pulsatile growth-hormone release
  • Growth-hormone secretagogue pathway
  • IGF-1 axis physiology
  • Body composition research
  • Selective receptor pharmacology

  • Published studies have investigated selective stimulation of growth-hormone release via the ghrelin receptor (GHSR-1a) in both animal models and human volunteers.
  • Research suggests dose-dependent increases in growth-hormone and IGF-1 concentrations without meaningful elevations in cortisol, prolactin, or thyroid-stimulating hormone in reported datasets.
  • Current evidence indicates preferential activity at the GHSR-1a receptor compared with other pituitary hormone axes, supporting a selective secretagogue profile.
  • Investigators have observed effects on body-composition parameters and markers of anabolic signaling when ipamorelin has been studied alongside GHRH-analogue compounds in published research.

Ipamorelin is being studied for its ability to selectively activate the ghrelin receptor (GHSR-1a) on pituitary somatotrophs, triggering endogenous, pulsatile growth-hormone secretion. Current evidence indicates that this activity occurs with minimal concurrent stimulation of corticotroph or lactotroph pathways, distinguishing it from less selective secretagogues. Increased growth-hormone release is associated with downstream hepatic IGF-1 production and anabolic signaling.
CURRENT AREAS OF INVESTIGATION
  • GH Axis
  • IGF-1 Signaling
  • Endocrine Research
  • Cellular Repair
  • Recovery
  • Healthy Aging

  1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1998;8(4):323-328. View source
  2. Johansen PB, Nowak C, Skjaerbaek C, et al. Ipamorelin, a new growth-hormone-releasing peptide, is selective for GH release in a rat model. Eur J Endocrinol. 1998;139(3):324-329. View source
  3. Gobburu JV, Szeffer SJ, Spielberg S. Pharmacokinetics of ipamorelin, a growth hormone secretagogue, in healthy volunteers. Eur J Clin Pharmacol. 1999;55(4):311-313. View source
  4. Svensson J, Lall S, Dickson SL, et al. The GH secretagogue ipamorelin counteracts the glucocorticoid-induced suppression of GH release in rats. Endocrinology. 2000;141(4):1497-1502. View source
  5. Torsello A, Ghe C, Bresciani E, et al. The growth hormone secretagogue ipamorelin, unlike ghrelin, does not increase anxiety in rats. Neuroendocrinology. 2002;75(4):226-232. View source
RESEARCH STATUS

This compound continues to be investigated in preclinical and/or clinical research. Scientific understanding continues to evolve as additional studies are published.

RESEARCH DISCLAIMER

For laboratory research use only. This information summarizes published scientific literature for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

RELATED · PERFORMANCE

More from this pillar

VIEW ALL
RESEARCH DISCLAIMER

All VELOR compounds are sold strictly for laboratory and research purposes only. They are not intended for human consumption, ingestion, or any food, drug, cosmetic, or therapeutic use. By purchasing, you confirm you are 21+ and a qualified researcher or research institution. Statements have not been evaluated by the FDA.

PERFORMANCE
Ipamorelin
$50.00
1